Marketable Securities	3 Months Ended
Mar. 31, 2022
Marketable Securities.
Marketable Securities	Note 3 – Marketable Securities Our marketable securities consist of equity securities classified as available-for-sale (“AFS”). AFS securities are carried at fair value on the condensed consolidated balance sheets. Unrealized gains and losses are reported in earnings within “other income (expense), net”. The specific identification method is used to determine realized gains and losses on AFS securities. During the three months ended March 31, 2022, we purchased $2.179 million of marketable equity securities. As of March 31, 2022, gross unrealized gains were $156 thousand, and gross unrealized losses were $0. As of March 31, 2022, our position in marketable equity securities had a historical cost of $2.179 million and a fair value of $2.335 million, as determined using Level 1 inputs on the fair value hierarchy.

Marketable Securities

3 Months Ended

Mar. 31, 2022

Note 3 – Marketable Securities

Our marketable securities consist of equity securities classified as available-for-sale (“AFS”). AFS securities are carried at fair value on the condensed consolidated balance sheets. Unrealized gains and losses are reported in earnings within “other income (expense), net”. The specific identification method is used to determine realized gains and losses on AFS securities. During the three months ended March 31, 2022, we purchased $2.179 million of marketable equity securities. As of March 31, 2022, gross unrealized gains were $156 thousand, and gross unrealized losses were $0. As of March 31, 2022, our position in marketable equity securities had a historical cost of $2.179 million and a fair value of $2.335 million, as determined using Level 1 inputs on the fair value hierarchy.